BiotechTube
Implant Surfaces

Implant Surfaces

San Diego, United States· Est.
implantsurfaces.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $14.5M

Overview

Implant Surfaces is a development-stage medical device company pioneering a quantum-level, multidisciplinary approach to implant surface engineering. Its core technology platform manipulates nanotopology to control biological responses, enabling products like osteoblast-promoting coatings, programmable antimicrobial silver oxide, and biocompatible ceramic coloring for metals and polymers. The company is preparing for commercial launches in 2024-2025, targeting the orthopedic, spinal, and broader implantable device markets with its 'Impossible Surfaces' solutions.

OrthopedicsSpinal SurgeryMedical Device Infection

Technology Platform

Multidisciplinary nanoscale surface engineering platform integrating physics, microbiology, protein chemistry, and immunochemistry to control biological responses through precise nanotopology. Enables design of surfaces for specific cell attachment, antimicrobial elution, biocompatible coloring, and other interface functions.

Funding History

2
Total raised:$14.5M
Series A$12M
Seed$2.5M

Opportunities

The company is positioned to capitalize on the large and growing market for advanced medical device coatings by solving two critical unmet needs: reliable osseointegration and programmable infection prevention.
Its platform technology also allows for expansion into high-margin, niche applications like device coloring and specialized non-attachment surfaces, creating multiple revenue streams from a core R&D foundation.

Risk Factors

Key risks include regulatory delays for its late-stage programs, the challenge of convincing large OEMs to adopt new surface technologies, and intense competition from established medical device coating companies.
Successful scale-up of nanoscale manufacturing processes while maintaining quality and consistency also presents a significant execution risk.

Competitive Landscape

Implant Surfaces competes in the specialized medical device coatings market against large orthopedic companies with in-house coating capabilities (e.g., Zimmer Biomet's OsseoTi, Stryker's Tritanium) and dedicated surface science firms. Its differentiation lies in its claimed quantum-level, multidisciplinary control of nanotopology for specific biological outcomes, a potentially more precise and tunable approach than many existing technologies.

More companies in Drug Delivery & Formulation →More companies in United States →